Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Tourette Syndrome
NCT00206323Phase 3Completed
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2004
- Primary completion
- Dec 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Tourette syndrome (TS) comparing Topiramate with Placebo (2 arms). Primary endpoint: Change From Baseline in Total Tic Score at Day 70. Started Sep 2004; status: completed.
02
Drugs
topiramate
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT00206323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206323.